Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTC
Year: 2026
Type: article
Study design: Observational Study
Source: Endocrine Related Cancer
DOI: 10.1530/erc-25-0461
Authors: Yara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, Frank Weber, David Kersting, Harald Lahner, Dagmar Führer, Tim Brandenburg
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Deutsche Forschungsgemeinschaft
OpenAlex ID: W7124428443
FWCI:
Cites:
Cited by:
Related to: